Illumina CFO Departs; Interim Appointed, New Director Joins Board

Ticker: ILMN · Form: 8-K · Filed: 2025-03-25T00:00:00.000Z

Sentiment: neutral

Topics: management-change, board-appointment, cfo-departure

Related Tickers: ILMN

TL;DR

CFO out, interim in, new board member joins. Watch for strategy shifts.

AI Summary

On March 24, 2025, Illumina, Inc. announced the departure of Chief Financial Officer, Joydeep Goswami, effective March 25, 2025. The company also announced the appointment of Arthur J. Rodrigues as interim CFO. Additionally, Illumina reported that its Board of Directors has appointed Dr. Siddhartha Mukherjee to the Board, effective March 24, 2025.

Why It Matters

The departure of a CFO and appointment of an interim can signal financial strategy shifts or instability. The addition of a new director may indicate a focus on specific strategic areas or governance changes.

Risk Assessment

Risk Level: medium — Changes in key financial leadership and board composition can introduce uncertainty regarding future financial strategy and operational direction.

Key Players & Entities

FAQ

Who has been appointed as the interim Chief Financial Officer of Illumina, Inc.?

Arthur J. Rodrigues has been appointed as the interim Chief Financial Officer of Illumina, Inc.

When is Joydeep Goswami's departure as CFO effective?

Joydeep Goswami's departure as CFO is effective March 25, 2025.

Who has been appointed to Illumina's Board of Directors?

Dr. Siddhartha Mukherjee has been appointed to Illumina's Board of Directors.

What is the effective date of Dr. Siddhartha Mukherjee's appointment to the Board?

Dr. Siddhartha Mukherjee's appointment to the Board is effective March 24, 2025.

What is the Commission File Number for Illumina, Inc.'s 8-K filing?

The Commission File Number for Illumina, Inc.'s 8-K filing is 001-35406.

From the Filing

0001110803-25-000032.txt : 20250325 0001110803-25-000032.hdr.sgml : 20250325 20250325161556 ACCESSION NUMBER: 0001110803-25-000032 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250325 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250325 DATE AS OF CHANGE: 20250325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILLUMINA, INC. CENTRAL INDEX KEY: 0001110803 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 330804655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35406 FILM NUMBER: 25768497 BUSINESS ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 8582024500 MAIL ADDRESS: STREET 1: 5200 ILLUMINA WAY CITY: SAN DIEGO STATE: CA ZIP: 92122 FORMER COMPANY: FORMER CONFORMED NAME: ILLUMINA INC DATE OF NAME CHANGE: 20000331 8-K 1 ilmn-20250325.htm 8-K ilmn-20250325 0001110803 FALSE March 25, 2025 0001110803 2025-03-25 2025-03-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form  8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2025 Illumina, Inc. (Exact name of registrant as specified in its charter) 001-35406 (Commission File Number) Delaware   33-0804655 (State or other jurisdiction of incorporation)   (I.R.S. Employer Identification No.) 5200 Illumina Way , San Diego , CA 92122 (Address of principal executive offices) (Zip code) ( 858 )  202-4500 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value ILMN The NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐      If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13a of the Exchange Act. o      Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On March 25, 2025, Stephen P. MacMillan, notified the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) of his intention to resign as a director of the Company, effective as of March 28, 2025. Mr. MacMillan’s resignation is not the result of any dispute or di

View on Read The Filing